Metraipolis › archive › dc_69fa6ecc87a9

Efficacy and Pulmonary Outcomes of Dual Immunotherapy Plus Chemotherapy Versus Standard Chemotherapy in Advanced Non-small Cell Lung Cancer — Europe PMC PMID:41479494

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41479494
DOI
10.7759/cureus.98184
License (as archived)
solo-consultazione
Archived
2026-11-08T03:46:54.861Z
SHA-256 of the archived text
60c090d6e751ffdd1006ccc80fe94a8ce52a1a77a42f27cdd9586d9ce79ef83f
Stable URL of this page
https://metraipolis.com/documento/dc_69fa6ecc87a9

How to cite

Efficacy and Pulmonary Outcomes of Dual Immunotherapy Plus Chemotherapy Versus Standard Chemotherapy in Advanced Non-small Cell Lung Cancer — Europe PMC PMID:41479494 — Europe PMC (en), https://europepmc.org/article/MED/41479494 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_69fa6ecc87a9 (Metraipolis archive dc_69fa6ecc87a9, sha256 60c090d6e751ffdd1006ccc80fe94a8ce52a1a77a42f27cdd9586d9ce79ef83f)
BibTeX
@misc{dc69fa6ecc87a9,
  title = {Efficacy and Pulmonary Outcomes of Dual Immunotherapy Plus Chemotherapy Versus Standard Chemotherapy in Advanced Non-small Cell Lung Cancer — Europe PMC PMID:41479494},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41479494},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_69fa6ecc87a9; sha256 60c090d6e751ffdd1006ccc80fe94a8ce52a1a77a42f27cdd9586d9ce79ef83f},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41479494. Agents can read the archived copy with the MCP tool read_document.